## Inflammatory Phase Cytokines in Fracture Healing **Key Point:** Transforming growth factor-beta (TGF-β) is the primary cytokine released by macrophages during the inflammatory phase (days 0–7) and serves as the master regulator of fracture healing. It recruits mesenchymal stem cells, promotes osteoblast differentiation, and stimulates angiogenesis. ### Cytokines in Fracture Healing Phases | Cytokine | Source | Phase | Primary Actions | |---|---|---|---| | **TGF-β** | Macrophages, platelets, bone matrix | Inflammatory (days 0–7) | Recruits MSCs; promotes osteoblast differentiation; angiogenesis; collagen synthesis | | BMP-2 (& BMP-7, -9) | Osteoblasts, bone matrix | Soft callus & ossification (days 7–21) | Potent osteoinductive; promotes osteoblast differentiation; bone formation | | TNF-α | Macrophages, neutrophils | Inflammatory (early) | Pro-inflammatory; enhances recruitment of immune cells; excessive levels impair healing | | IL-10 | Macrophages, T cells | Late inflammatory/early callus | Anti-inflammatory; resolves inflammation; promotes transition to callus phase | | VEGF | Endothelial cells, osteoblasts | Soft callus & ossification | Angiogenesis; vascular invasion | **High-Yield:** TGF-β is the **earliest and most abundant** growth factor in fracture healing and is the primary driver of the transition from inflammation to callus formation. It is considered the "master regulator" of fracture healing. **Mnemonic:** **"TGF-β: The Transformer"** — TGF-β transforms the inflammatory phase into the callus phase by recruiting and differentiating osteoblasts. **Clinical Pearl:** NSAIDs (e.g., indomethacin) inhibit TGF-β and prostaglandin synthesis, which is why prolonged NSAID use delays fracture healing. 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.